Live from the NIH registry
Studies recruiting near Anaheim right now
Top 25 of 3,181 recruiting studies, sorted by proximity — each links to its official registry page
Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia
Phase 1
Interventional 40 participants sought
The Center for Comprehensive Care and Diagnosis of Inherited Blood Disorders (CIBD) — Orange, California (3.5 mi)
· Sponsor: Bleeding and Clotting Disorders Institute Peoria, Illinois
Assessing Improvements in Mood and Sleep Trial
Depression, Suicidality
N/A
Interventional 420 participants sought
The Regents of the University of California, Los Angeles — Los Angeles, California (26.6 mi)
· Sponsor: University of Pittsburgh
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Gonorrhea, Chlamydia
Phase 4
Interventional 760 participants sought
UCLA Care — Los Angeles, California (26.6 mi)
· Sponsor: Westat
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
City of Hope Comprehensive Cancer Center ( Site 0191) — Duarte, California (21.9 mi)
· Sponsor: Merck Sharp & Dohme LLC
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
City of Hope National Medical Center — Duarte, California (21.9 mi)
· Sponsor: Relay Therapeutics, Inc.
Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients
Non-segmental Vitiligo
Phase 2
Interventional 45 participants sought
Marvel Clinical Research — Huntington Beach, California (14.8 mi)
· Sponsor: Elixiron Immunotherapeutics (Hong Kong) Ltd.
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
Retina Associates of Southern California — Huntington Beach, California (14.8 mi)
· Sponsor: Boehringer Ingelheim
Shorter Versus Extended Course of Antibiotic Therapy for Necrotizing Soft Tissue Infections
Necrotizing Soft Tissue Infection
N/A
Observational 50 participants sought
University of California Irvine Medical Center — Orange, California (3.5 mi)
· Sponsor: University of California, Irvine
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Children's Hospital of Orange County — Orange, California (3.5 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
Migraine
Phase 2
Interventional 488 participants sought
Clinical Research Institute, LCC — Los Angeles, California (26.6 mi)
· Sponsor: AbbVie
A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
Hidradenitis Suppurativa
Phase 2
Interventional 90 participants sought
First OC Dermatology Research — Fountain Valley, California (10.5 mi)
· Sponsor: Takeda
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
Fibromyalgia
Phase 3
Interventional 620 participants sought
Clinical Research Site — Anaheim, California (3.3 mi)
· Sponsor: Axsome Therapeutics, Inc.
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
Solid Tumors
Phase 2
Interventional 170 participants sought
Southern California Permanente Medical Group — Bellflower, California (15.2 mi)
· Sponsor: Mirati Therapeutics Inc.
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Orange County Retina Med Group — Santa Ana, California (6.5 mi)
· Sponsor: Genentech, Inc.
A First-in-human (FIH), Phase I Study of PTX-912 in Patients with Locally Advanced/Metastatic Solid Tumors
Advanced Cancer, Solid Tumor
Phase 1
Interventional 26 participants sought
City of Hope National Medical Center — Duarte, California (21.9 mi)
· Sponsor: Proviva Therapeutics, Inc.
Study Evaluating the Quality and Effects of Lion's Mane Product on Cognitive Health
Cognitive Decline
N/A
Observational 150 participants sought
People Science — Los Angeles, California (26.6 mi)
· Sponsor: M2 Ingredients
PEACE Trial: Postpartum Evaluation of Antihypertensive Cessation and Efficacy
Postpartum Hypertension (PPHT)
Phase 4
Interventional 110 participants sought
UCLA Ronald Reagan — Los Angeles, California (26.6 mi)
· Sponsor: University of California, Los Angeles
Developing an Innovative Decision Support Tool for Pediatric Neuromuscular Scoliosis
Children With Medical Complexity (CMC), Multiple Chronic Conditions
N/A
Interventional 110 participants sought
Children's Hospital Los Angeles — Los Angeles, California (26.6 mi)
· Sponsor: University of Utah
Towards Restoring Complex Movement After Paralysis: Algorithm Development With Healthy Participants
Movement Disorders, Neurorehabilitation
N/A
Interventional 50 participants sought
UCLA Neural Engineering and Computation Lab — Los Angeles, California (26.6 mi)
· Sponsor: University of California, Los Angeles
ATLAS-1: Advanced Trial for Longitudinal Assessment in Salma 1
Depressed Mood
N/A
Observational 5,000 participants sought
Salma Health — Laguna Hills, California (17.7 mi)
· Sponsor: Salma Health, Inc.
Congenital Muscle Disease Study of Patient and Family Reported Medical Information
Multiple conditions
N/A
Observational 4,000 participants sought
Congenital Muscle Disease International Registry (www.cmdir.org) — Lakewood, California (15.9 mi)
· Sponsor: Cure CMD
Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
Age-Related Macular Degeneration, Geographic Atrophy
N/A
Interventional 125 participants sought
Eye Physicians of Long Beach — Long Beach, California (19.7 mi)
· Sponsor: VisionCare, Inc.
Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors
Breast Carcinoma, Chemotherapy-Induced Peripheral Neuropathy
Phase 2
Interventional 120 participants sought
City of Hope at Irvine Lennar — Irvine, California (11.9 mi)
· Sponsor: City of Hope Medical Center
YAG Laser Vitreolysis for Vitreous Floaters
Posterior Vitreous Detachment, Myopic Vitreopathy
N/A
Interventional 50 participants sought
VMR Institute for Vitreous Macula Retina — Huntington Beach, California (14.8 mi)
· Sponsor: VMR Consulting, Inc.
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Irvine, California (11.9 mi)
· Sponsor: AstraZeneca